Your session is about to expire
← Back to Search
Angiomammography for Breast Cancer Response Prediction
Study Summary
This trial is looking at whether a less expensive and more readily available diagnostic modality, namely CESM, is as effective as MRI in predicting the response of a malignant breast tumor to neoadjuvant chemotherapy and the chances of achieving a pCR.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have severe kidney problems.You have health conditions that make it unsafe for you to have an MRI scan.I have received chemotherapy before surgery, with or without targeted therapy.My cancer has not spread to distant parts of my body.You have a known reason that makes it unsafe for you to have contrast dye.My breast cancer was confirmed with a biopsy.My breast tumor can be felt and measured by a doctor.I have an overactive thyroid.I refuse to undergo a biopsy or surgery.You are allergic to contrast dye.I am a woman aged 18 or older.
- Group 1: Neoadjuvant chemotherapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any remaining openings for participants in this trial?
"Affirmative. Clinicaltrials.gov maintains that this clinical trial, which was first posted on March 1st 2018, is currently recruiting patients from one location with a total of 100 participants needed."
How many people are actively participating in this experiment?
"Affirmative, the available information from clinicaltrials.gov states that this experiment is actively recruiting volunteers. It was published on March 1st 2018 and updated June 10th 2022, seeking 100 individuals from one site."
Share this study with friends
Copy Link
Messenger